ArticlePregnancy (Hoboken, N.J.)2025
The impact of COVID-19 infection on neonatal birth weight and outcomes.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since its outbreak in 2019, the novel severe acute respiratory syndrome coronavirus-2 (COVID-19) outbreak has had a devastating impact worldwide. Pregnancy has been shown to worsen the clinical outcome in those affected with COVID-19 infection. While data demonstrate poorer maternal outcomes in those infected with COVID-19, published studies on neonatal outcomes after antenatal maternal infection are conflicting-specifically as it relates to neonatal birth weight. We hypothesize that maternal COVID-19 infection increases the risk for small-for-gestational age (SGA) neonatal birth weight. Objective: (1) To estimate the association between antenatal maternal COVID-19 infection and the risk for SGA and (2) to assess whether gestational timing of infection or severity of COVID-19 infection differentially impacts the risk of SGA. Study design: This was a retrospective cohort study that included all pregnant patients with COVID-19 infection and that randomly selected uninfected controls from October 2020 to June 2022 at a single tertiary care center. Multivariable logistic regression was performed to estimate the independent effect of maternal COVID-19 infection on SGA neonatal birth weight. We used similar logistical regression models to estimate the independent effect of COVID-19 exposure on SGA stratified by trimester and COVID-19 severity. Results: Of 1011 patients in the study, 502 patients had COVID-19 infection. Overall, COVID-19 infection was not associated with an increased risk of SGA, adjusting for confounding by maternal age, hypertension, pre-gravid body mass index (BMI), and race. However, first trimester infection was associated with a twofold increased risk in SGA (adjusted odds ratio [aOR], 2.3; 95% confidence interval [CI], 1.1-5.1), compared to uninfected controls, while infection in the second and third trimesters was not associated with SGA. Moderate/severe disease was associated with a twofold increased risk of SGA (aOR, 2.1; 95% CI, 1.1-3.5) compared to uninfected controls. Conclusion: While COVID-19 infection was not uniformly associated with SGA in the whole cohort, individuals with moderate/severe disease or those exposed in the first trimester had an increased risk of delivering an SGA neonate. Fetal growth surveillance for COVID-19 infection can be reserved for those with moderate/severe infection or those infected in the first trimester.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.